CY1109440T1 - Φωσφοϊνδολες ως αναστολεις hiv - Google Patents

Φωσφοϊνδολες ως αναστολεις hiv

Info

Publication number
CY1109440T1
CY1109440T1 CY20091100127T CY091100127T CY1109440T1 CY 1109440 T1 CY1109440 T1 CY 1109440T1 CY 20091100127 T CY20091100127 T CY 20091100127T CY 091100127 T CY091100127 T CY 091100127T CY 1109440 T1 CY1109440 T1 CY 1109440T1
Authority
CY
Cyprus
Prior art keywords
phosphosphols
hiv inhibitors
compounds
hiv
retroviral
Prior art date
Application number
CY20091100127T
Other languages
English (en)
Inventor
Richard Storer
Cyril Dousson
François-René Alexandre
Arlène Roland
Original Assignee
Idenix Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36407947&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1109440(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Idenix Pharmaceuticals, Inc. filed Critical Idenix Pharmaceuticals, Inc.
Publication of CY1109440T1 publication Critical patent/CY1109440T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)

Abstract

Περιγράφονται ενώσεις 3-φωσφοϊνδόλης για την θεραπευτική αγωγή ρετροϊικών λοιμώξεων, και ιδίως για HIV. Περιλαμβάνονται επίσης συνθέσεις που περιλαμβάνουν παράγωγα 3-φωσφοϊνδόλης μόνα τους ή σε συνδυασμό με έναν ή περισσότερους αντι-ιικούς παράγοντες, διαδικασίες για την παρασκευή τους, και μέθοδοι παρασκευής φαρμάκου που ενσωματώνει αυτές τις ενώσεις.
CY20091100127T 2004-09-17 2009-02-04 Φωσφοϊνδολες ως αναστολεις hiv CY1109440T1 (el)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US61106104P 2004-09-17 2004-09-17
US71144505P 2005-08-25 2005-08-25
US71156505P 2005-08-26 2005-08-26
EP05850774A EP1799696B1 (en) 2004-09-17 2005-09-16 Phosphoindoles as hiv inhibitors

Publications (1)

Publication Number Publication Date
CY1109440T1 true CY1109440T1 (el) 2014-08-13

Family

ID=36407947

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100127T CY1109440T1 (el) 2004-09-17 2009-02-04 Φωσφοϊνδολες ως αναστολεις hiv

Country Status (25)

Country Link
US (2) US7534809B2 (el)
EP (3) EP1799696B1 (el)
JP (1) JP5031569B2 (el)
KR (1) KR101242962B1 (el)
CN (1) CN102304150B (el)
AT (2) ATE479693T1 (el)
AU (1) AU2005305609B2 (el)
BR (1) BRPI0515344A (el)
CA (1) CA2583409C (el)
CY (1) CY1109440T1 (el)
DE (2) DE602005011031D1 (el)
DK (1) DK1799696T3 (el)
ES (1) ES2320252T3 (el)
HK (1) HK1100142A1 (el)
HR (1) HRP20090086T3 (el)
IL (1) IL181909A0 (el)
MX (1) MX2007003040A (el)
NO (1) NO20071871L (el)
NZ (1) NZ554232A (el)
PL (1) PL1799696T3 (el)
PT (1) PT1799696E (el)
RS (1) RS50981B (el)
SG (1) SG155939A1 (el)
SI (1) SI1799696T1 (el)
WO (1) WO2006054182A2 (el)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005305609B2 (en) * 2004-09-17 2011-10-06 Idenix Pharmaceuticals, Inc. Phosphoindoles as HIV inhibitors
NZ575831A (en) * 2006-09-29 2011-12-22 Idenix Pharmaceuticals Inc Enantiomerically pure phosphoindoles as hiv inhibitors
US20100113421A1 (en) * 2006-10-06 2010-05-06 Williams Theresa M Non-nucleoside reverse transcriptase inhibitors
EA016386B1 (ru) 2007-05-30 2012-04-30 Ф. Хоффманн-Ля Рош Аг Ненуклеозидные ингибиторы обратной транскриптазы
TW200946541A (en) * 2008-03-27 2009-11-16 Idenix Pharmaceuticals Inc Solid forms of an anti-HIV phosphoindole compound
TW200944537A (en) * 2008-04-03 2009-11-01 Idenix Pharmaceuticals Inc Formulations comprising a phosphoindole compound and one or more second active agents
US8309737B2 (en) * 2009-02-03 2012-11-13 Idenix Pharmaceuticals, Inc. Phosphinate ruthenium complexes
US8193372B2 (en) 2009-03-04 2012-06-05 Idenix Pharmaceuticals, Inc. Phosphothiophene and phosphothiazole HCV polymerase inhibitors
KR20170078868A (ko) 2010-01-27 2017-07-07 비이브 헬쓰케어 컴퍼니 항바이러스 치료
CN103275126B (zh) * 2013-05-28 2016-03-23 兰州大学 一种立体选择性合成3-位膦酰化吲哚的方法
ITMI20131218A1 (it) * 2013-07-19 2015-01-20 Need Pharma Srl Nuovi ureido derivati di acidi naftalensolfonici
EP3695225A4 (en) * 2017-10-13 2021-06-30 Ursure, Inc. PRODUCTS AND METHODS FOR MONITORING ADHERENCE IN NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR THERAPY

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4866084A (en) 1987-07-17 1989-09-12 Harbor Branch Oceanographic Institution, Inc. Topsentin compounds effective against viruses and certain tumors
US5124327A (en) 1991-09-06 1992-06-23 Merck & Co., Inc. HIV reverse transcriptase
US5527819A (en) 1991-09-06 1996-06-18 Merck & Co., Inc. Inhibitors of HIV reverse transcriptase
DE4217964A1 (de) 1992-05-30 1993-12-02 Goedecke Ag Indolocarbazol-Imide und deren Verwendung
CA2156420A1 (en) 1993-02-24 1994-09-01 Theresa M. Williams Inhibitors of hiv reverse transcriptase
US5424329A (en) 1993-08-18 1995-06-13 Warner-Lambert Company Indole-2-carboxamides as inhibitors of cell adhesion
US5612330A (en) 1994-03-07 1997-03-18 Warner-Lambert Company Methods for inhibiting and controlling viral growth
US5489586A (en) 1994-03-07 1996-02-06 Warner-Lambert Company Method for treating inflammatory disease in humans
US5489685A (en) 1994-05-12 1996-02-06 Merck & Co., Ltd. Method of synthesizing furo[2,3-b]pyridine carboxylic acid esters
ES2172585T3 (es) 1994-05-31 2002-10-01 Mitsui Chemicals Inc Derivado de benzoimidazol.
US5734081A (en) 1994-08-05 1998-03-31 Warner-Lambert Company Arylthio compounds
JPH10512251A (ja) 1995-01-10 1998-11-24 スミスクライン・ビーチャム・ソシエタ・ペル・アチオニ 骨粗鬆症の治療に有用なインドール誘導体
US6011021A (en) * 1996-06-17 2000-01-04 Guilford Pharmaceuticals Inc. Methods of cancer treatment using naaladase inhibitors
US6025345A (en) 1996-06-17 2000-02-15 Guilford Pharmaceuticals Inc. Inhibitors of NAALADase enzyme activity
US6025344A (en) * 1996-06-17 2000-02-15 Guilford Pharmaceuticals Inc. Certain dioic acid derivatives useful as NAALADase inhibitors
US6046180A (en) * 1996-06-17 2000-04-04 Guilford Pharmaceuticals Inc. NAALADase inhibitors
US6017903A (en) 1996-09-27 2000-01-25 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
GB9614347D0 (en) 1996-07-09 1996-09-04 Smithkline Beecham Spa Novel compounds
CZ60499A3 (cs) 1996-09-27 1999-08-11 Guilford Pharmaceuticals Inc. Prostředky s účinkem na NAALADázy, způsoby léčení glutamátové abnormality a způsoby ovlivňování neuronální aktivity u živočichů
US5830894A (en) 1997-02-21 1998-11-03 Viropharma Incorporated Methods for preventing and treating pestivirus infection and associated diseases
US6068988A (en) * 1997-02-28 2000-05-30 Biosynth Ag Detection of microbial metabolites with a 3-indoxyl-myo-inositol-1-phosphate compound
US5935982A (en) 1997-02-28 1999-08-10 The University Of North Carolina At Chapel Hill Methods of treating retroviral infection and compounds useful therefor
WO1998053812A1 (en) * 1997-05-27 1998-12-03 Guilford Pharmaceuticals Inc. Inhibitors of naaladase enzyme activity
RU2217421C2 (ru) 1998-03-26 2003-11-27 Шионоги & Ко., Лтд. Производные индола, обладающие антивирусной активностью
IT1299068B1 (it) 1998-04-10 2000-02-07 Chemi Spa Legandi fosforati chirali e loro complessi organometallici, utili come catalizzatori in sintesi stereoselettive
GB9914371D0 (en) 1999-06-18 1999-08-18 Smithkline Beecham Plc Novel compounds
WO2002083126A1 (en) 2001-04-11 2002-10-24 Idenix (Cayman) Limited Phenylindoles for the treatment of hiv
US6825201B2 (en) 2001-04-25 2004-11-30 Bristol-Myers Squibb Company Indole, azaindole and related heterocyclic amidopiperazine derivatives
JP3368273B1 (ja) * 2001-12-28 2003-01-20 株式会社トミー 動作玩具の駆動装置及び動作玩具
US20030236277A1 (en) 2002-02-14 2003-12-25 Kadow John F. Indole, azaindole and related heterocyclic pyrrolidine derivatives
BR0309557A (pt) 2002-04-26 2005-03-01 Gilead Sciences Inc Inibidores da transcriptase reversa não nucleosìdeos
US6900206B2 (en) 2002-06-20 2005-05-31 Bristol-Myers Squibb Company Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives
US20040063746A1 (en) 2002-07-25 2004-04-01 Alicia Regueiro-Ren Indole, azaindole and related heterocyclic ureido and thioureido piperazine derivatives
WO2004014364A1 (en) 2002-08-07 2004-02-19 Idenix (Cayman) Limited Substituted phenylindoles for the treatment of hiv
AU2005305609B2 (en) 2004-09-17 2011-10-06 Idenix Pharmaceuticals, Inc. Phosphoindoles as HIV inhibitors
NZ575831A (en) * 2006-09-29 2011-12-22 Idenix Pharmaceuticals Inc Enantiomerically pure phosphoindoles as hiv inhibitors

Also Published As

Publication number Publication date
WO2006054182A3 (en) 2007-03-01
EP1799696A2 (en) 2007-06-27
PT1799696E (pt) 2009-02-16
HK1100142A1 (en) 2007-09-07
WO2006054182A2 (en) 2006-05-26
US20060074054A1 (en) 2006-04-06
MX2007003040A (es) 2007-08-02
NO20071871L (no) 2007-05-15
ATE479693T1 (de) 2010-09-15
US7534809B2 (en) 2009-05-19
US20090163444A1 (en) 2009-06-25
SI1799696T1 (sl) 2009-04-30
CA2583409C (en) 2014-06-17
ATE414092T1 (de) 2008-11-15
KR20070063545A (ko) 2007-06-19
CA2583409A1 (en) 2006-05-26
PL1799696T3 (pl) 2009-04-30
EP1961757B1 (en) 2010-09-01
EP2256124A1 (en) 2010-12-01
BRPI0515344A (pt) 2008-07-15
DE602005011031D1 (en) 2008-12-24
AU2005305609B2 (en) 2011-10-06
NZ554232A (en) 2010-09-30
WO2006054182A9 (en) 2006-08-17
DE602005023360D1 (de) 2010-10-14
JP2008515782A (ja) 2008-05-15
KR101242962B1 (ko) 2013-03-13
JP5031569B2 (ja) 2012-09-19
AU2005305609A1 (en) 2006-05-26
HRP20090086T3 (en) 2009-03-31
ES2320252T3 (es) 2009-05-20
EP1961757A1 (en) 2008-08-27
DK1799696T3 (da) 2009-03-09
RS50981B (sr) 2010-10-31
SG155939A1 (en) 2009-10-29
US8044091B2 (en) 2011-10-25
CN102304150B (zh) 2014-06-18
CN102304150A (zh) 2012-01-04
EP1799696B1 (en) 2008-11-12
IL181909A0 (en) 2007-07-04

Similar Documents

Publication Publication Date Title
CY1109440T1 (el) Φωσφοϊνδολες ως αναστολεις hiv
NO20064547L (no) Fremgangsmater for behandling av HIV infeksjon
TR200201187T2 (tr) Ters transkriptazın inhibitörleri olarak benzofenonlar
DE60336664D1 (de) Nichtnukleosidische reverse-transkriptase-hemmer
DK1938839T3 (da) Oftalmiske sammensætninger af parasympatiske stimulanter og anti-inflammatoriske midler til anvendelse i behandlingen af presbyopi
BRPI0717266A2 (pt) Derivados de oxindol
DE602004021644D1 (de) Gyraseinhibitoren und deren verwendungen
WO2007112014A3 (en) New therapeutic combinations for the treatment of depression
CL2007002671A1 (es) Compuestos derivados de octahidro-pirrolo[3,4-c]pirrol; composicion farmaceutica que la comprende; y uso del compuesto en el tratamiento del vih, sida o arc.
CL2007002346A1 (es) Compuestos no nucleosidicos derivados de fenoxi-fenil sustituidos, inhibidores de la transcriptasa inversa del vih; composicion farmaceutica; y su uso para tratar prevenir una infeccion vih o para tratar el sida o crs.
MX2023002233A (es) Compuestos fosfolipidos y usos de estos.
CL2007001826A1 (es) Compuestos derivados de 2-(amino-sustituido)-benzotiazol-sulfonamida, inhibidores de proteasa, en particular, inhibidores de proteasa de vih; composicion farmaceutica; y uso para tratar o combatir una infeccion o enfermedad asociada con la infeccion de un retrovirus resistente a multiples farmacos.
WO2006042478A8 (fr) Inhibiteurs de petites molecules de la protease principale des coronavirus, leur preparation et utilisation
TW200716571A (en) Heterocyclic reverse transcriptase inhibitors
DK1838716T3 (da) Olanzapinpamota-dihydrat
WO2022063869A3 (en) Compounds for the treatment of viral infections
WO2006132947A3 (en) 3-acyl coumarins, thiochromones and quinolones and therapeutic uses thereof
BRPI0510407A (pt) derivados de 3-amino-2-fenilpirrolidina
WO2004096147A3 (en) Oxo-pyrimidine compounds
UA88325C2 (en) Phosphoindoles as hiv inhibitors
UY31541A1 (es) 1(2)h-tetrazol-5-il-fenil-oxazolidinona s como agentes antibacterianos
CY1112164T1 (el) Παραγωγα 1-[2'-3'-διδεοξυ-3'-c-(υδροξυμεθυλ)-βητα-d-ερυθρο-πεντοφουρανοσυλ] κυτοσινης ως αναστολεις toy hiv
TW200744581A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
CL2007003687A1 (es) Compuestos derivados de 1-oxo-pirido[3,4-d]piridazina o 1-oxo-ftalazina; composicion farmaceutica; y uso para el tratamiento de una enfermedad inflamatoria y/o alergica tal como rinitis alergica.